Related Experiment Videos
Microarray screening for target genes of the proto-oncogene PLAG1
Marianne L Voz1, Janick Mathys, Karen Hensen
1Laboratory for Molecular Oncology, Center for Human Genetics, KU Leuven & Flanders Interuniversity Institute for Biotechnology, Herestraat 49, Leuven B-3000, Belgium. mvoz@ulg.ac.be
Oncogene
|January 9, 2004
Summary
Proto-oncogene PLAG1 drives tumor development by deregulating gene expression. Identifying PLAG1 target genes, like growth factors, is key to understanding tumorigenesis and developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- PLAG1 is a proto-oncogene implicated in salivary gland pleomorphic adenomas and lipoblastomas.
- Ectopic PLAG1 expression deregulates target genes, promoting uncontrolled cell proliferation.
- Understanding PLAG1's molecular mechanisms requires identifying its target genes.
Purpose of the Study:
- To identify genes directly regulated by PLAG1.
- To elucidate the molecular mechanisms underlying PLAG1-induced tumorigenesis.
- To find potential therapeutic targets for PLAG1-driven cancers.
Main Methods:
- Conditional induction of PLAG1 expression in fetal kidney 293 cell lines.
- Oligonucleotide microarray analysis of approximately 12,000 genes.
- In silico analysis of PLAG1 consensus sequences in gene promoters.
- Comparison of gene expression profiles in PLAG1-induced tumors and normal tissues.
Main Results:
- PLAG1 induction upregulated 47 genes and downregulated 12 genes.
- Upregulated targets include growth factors like insulin-like growth factor II and cytokine-like factor 1.
- A significant proportion of upregulated genes contain PLAG1-binding motifs, suggesting direct regulation.
- Twelve genes were consistently upregulated in both PLAG1-expressing cells and pleomorphic adenomas.
Conclusions:
- PLAG1 directly regulates a set of target genes, including key growth factors.
- These findings provide crucial insights into PLAG1-mediated tumorigenesis.
- Identified PLAG1 targets represent potential biomarkers and therapeutic targets for relevant cancers.